Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Karim Chikh

Inappropriate Glucagon and GLP-1 Secretion in Individuals With Long-Standing Type 1 Diabetes: Effects of Residual C-Peptide

Diabetologia

English

Variability Among TSH Measurements Can Be Reduced by Combining a Glycoengineered Calibrator to Epitope-Defined Immunoassays

European Thyroid Journal

English

Related publications

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology

Internal Medicine

Cardiology

Endocrinology

Cardiovascular Medicine

Metabolism

Diabetes

2014

English

Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

English

Residual C-Peptide Secretion and Endothelial Function in Patients With Type II Diabetes

Clinical Science

Medicine

2003

English

Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 (GLP-1) Gene Therapy for Diabetes

English

Response to “Preserved” Glucagon Secretion in Fulminant Type 1 Diabetes

Journal of Diabetes Investigation

English

Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Science-Business eXchange

2009

English

Pdb112 - Treatment and Dosing Patterns Among Patients With Type 2 Diabetes (T2d) Initiating Glucagon-Like Peptide-1 Receptor Agonists (Glp-1 Ras) in Several Countries

English

Glucagon, GLP-1 and Thermogenesis

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

Inappropriate Glucagon Response After Oral Compared With Isoglycemic Intravenous Glucose Administration in Patients With Type 1 Diabetes

American Journal of Physiology - Endocrinology and Metabolism

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Karim Chikh

Inappropriate Glucagon and GLP-1 Secretion in Individuals With Long-Standing Type 1 Diabetes: Effects of Residual C-Peptide

Variability Among TSH Measurements Can Be Reduced by Combining a Glycoengineered Calibrator to Epitope-Defined Immunoassays

Related publications

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM

Residual C-Peptide Secretion and Endothelial Function in Patients With Type II Diabetes

Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 (GLP-1) Gene Therapy for Diabetes

Response to “Preserved” Glucagon Secretion in Fulminant Type 1 Diabetes

Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)

Pdb112 - Treatment and Dosing Patterns Among Patients With Type 2 Diabetes (T2d) Initiating Glucagon-Like Peptide-1 Receptor Agonists (Glp-1 Ras) in Several Countries

Glucagon, GLP-1 and Thermogenesis

Inappropriate Glucagon Response After Oral Compared With Isoglycemic Intravenous Glucose Administration in Patients With Type 1 Diabetes